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Human papillomaviruses (HPVs) are ubiquitous, well adapted to their host and cleverly sequestered away
from immune responses. HPV infections can be productive, subclinical or latent in both skin and mucosa.
The causal association of HPV with cervical cancer, and increasingly with rising numbers of squamous
cell carcinomas at other sites in both men and women, is increasingly recognised, while the morbidity of
cutaneous HPV lesions, particularly in the immunosuppressed population is also signiﬁcant. This chapter
sets out the range of infections and clinical manifestations of the consequences of infection and its
persistence and describes why HPVs are both highly effective pathogens and carcinogens, challenging to
eliminate.
& 2013 Elsevier Inc. All rights reserved.Introduction
The papillomaviridae are ancient and ubiquitous viruses, with
over 200 types of species-speciﬁc viruses classiﬁed into 16 genera.
PVs preferentially infect differentiating squamous epithelium and in
humans, almost every part of human skin can be infected. HPV was
the ﬁrst known human tumour virus, associated with benign,
epithelial proliferations or papillomas and there are now 120
different HPV types ofﬁcially recognised with others pending
classiﬁcation (Bernard et al., 2010). In recent decades, the causal
association of HPV with cervical cancer, but also with an increasing
number of squamous cell carcinomas at speciﬁc sites, has been
recognised. This chapter sets out the range of infections and clinical
manifestations of the consequences of infection and its persistence.
HPVs are divided into three main groups: cutaneous, mucocu-
taneous and those associated with the rare autosomal recessive
disorder, epidermodysplasia verruciformis (EV). The cutaneous
HPVs belong to the beta genus with a few members in the gamma,
mu and nu genera, while the alpha genus contains all of the
mucosal HPVs and a few cutaneous types (Bernard et al., 2010).
They can also be grouped according to the areas of the body where
infection is found – external skin, anogenital and oral regions. The
mucocutaneous HPV types can be further sub-divided into low
risk (LR-HPV) mainly associated with benign warts and high risk
(HR-HPV) deﬁned by their risk of progression to malignancy.
While certain HPV types are associated with particular morpho-
logical characteristics, the association is not absolute and HPV
infection can be productive, subclinical or latent in both skin andll rights reserved.
hs.uk,mucosa. Productive lesions such as warts can be seen clinically,
while sub-clinical mucosal infections need additional tools such as
microscopic examination with the aid of topically applied acetic
acid, as in colposcopic examination of the cervix or anoscopy
of the anal canal. Latent papillomaviruses are detectable only
through the demonstration of HPV DNA in clinically and histolo-
gically normal skin and mucosa. Productive infections are asso-
ciated with full viral gene expression and production of mature
virus particles, while in persistent infections, normal cell function
is abrogated and late events in the virus life cycle are disrupted.
Approximately 70% of HPV infections resolve spontaneously in
1 year and 90% in 2 years, while HPV persistence develops in the
remainder (Veldhuijzen et al., 2010). Clearance requires an effec-
tive cell mediated immune response, while persistent infection
with HR-HPV types represents a failure of the immune response
and increases the risk of progression to cancer (Stanley, 2010).
Table 1 shows the HPV types most frequently associated with
particular diseases.HPV in external skin
Warts have been recognised since Greek and Roman times,
since when and in many cultures, warts have been associated with
magic and a multitude of folk cures, due to the sudden appearance
and disappearance of warts (Bunney et al., 1992). Cutaneous warts
are spread either by direct contact from person to person or
indirectly by contact with contaminated surfaces or objects,
transmission being facilitated by minor breaks in the epidermal
barrier. Re-infection and autoinoculation, particularly in children,
are important methods of spread and include transmission to the
oral region by sucking and chewing of ﬁngers, spread from one
H.A. Cubie / Virology 445 (2013) 21–3422child to another, through contact games and from hand to face or to
elbows and knees through minor abrasions. Prevalence varies across
different populations and age ranges, but is highest in children andTable 1
HPV types associated with particular diseases (adapted from several sources).
Disease
Common warts
Flat plane warts
Plantar warts
Epidermodysplasia verruciformis Plane warts
Pityriasis-like plaques
Squamous cell carcinomas of sun-exposed skin
Anogenital warts External warts
Buschke–Lowenstein tumour
Bowenoid papulosis
Anogenital cancers and precancers Group 1: Carcinogenic to humans
Group 2A: Probably carcinogenic to humans
Group 2B: Possibly carcinogenic to humans
Oral lesions Oral papillomas
Laryngeal papillomas
Focal hyperplasia (Heck's disease)
Oropharyngeal carcinoma
Fig. 1. Histology of an exophytic wart. (a) Section of exophytic wart showing hyperke
micrograph of virus particles in crystalline array in nuclei of granulocytic and superﬁcaadolescents at an estimated 3–5% (Williams et al., 1993). Studies from
some time ago suggested prevalence rates as high as 10% in 1955
in children aged 5–18 in UK and 20% in 1980 in children aged 12–16Most frequently associated HPV types
HPV 2, 4, 7; occasionally other types in immunosuppressed (e.g. HPV 75–77)
HPV 3, 10, occasionally HPV 26–29 and 41
HPV 1, 2, 4
HPV 3, 10
HPV 5, 8; less commonly 9,12,14,15, 17, 19,20, 21–25, 36–39, 47,49
HPV 5, 8, less commonly 14,17,20 and 47
HPV 6, 11, 40, 42, 43, 44, 54, 61, 72, 81, 89
HPV 6
HPV 16, 55
HPV 16,18, 31, 33, 45, 51, 52
HPV 68
HPV 26, 53, 64, 65, 66, 67, 69, 70, 73, 82
HPV 2,6,7,11,16,18,32,57
HPV 6,11
HPV 13, 32
HPV 16 predominantly,18
ratosis of upper layers of epidermis and hypertrophy of basal layers. (b) Electron
l layers of HPV1 associarted plantar wart.
H.A. Cubie / Virology 445 (2013) 21–34 23in Sweden (Larsson and Liden, 1980). It is not known if the prevalence
has truly fallen or whether home and primary care treatment options
have simply reduced the workload of dermatology clinics from the
high peaks seen in earlier decades. More detail on the natural history
and epidemiology of cutaneous warts can be found in recent reviews
by Benton (2005) and Cardoso and Calonje (2011).
Histologically, warts are benign lesions, with hypertrophy of all
layers of the dermis (Fig. 1a), resulting in acanthosis (thickening),
papillomatisis (folding) and hyperkeratosis (increase in the horny
layer) often with abnormal keratohyaline granules. Vacuolation of
cells occurs in the upper layers and inclusion bodies are some-
times observed. Different types of cutaneous warts can show
characteristic changes and for the interested reader, the histologi-
cal illustrations in Croissant et al. (1985) remain useful. Resolution
using the electron microscope reveals densely packed virus
particles in crystalline array in the upper stratum granulosum
and stratum corneum (Fig. 1b). Warts usually disappear sponta-
neously but occasionally may be resistant to treatment. Regrowth
of lesions after treatment is frequently due to persistence of the
virus in the skin surrounding the original wart.
Common warts of hands and face
Common warts are usually exophytic, multiple, irregular, rough
nodules which show a variety of clinical patterns at different sites of
trauma particularly on ﬁngers (Fig. 2), but also on other frequentlyFig. 2. Common warts on hands (HPV 2 associated). (a) Multiple common warts acros
immunosuppression.rubbed and abraded skin surfaces such as hands, elbows and knees.
They range from small papules to large, hyperkeratotic, ﬁssured
cauliﬂower-like lesions. Common warts are most frequently caused
by HPV 2 while the smaller, endophytic, punctate lesions most often
seen on the palms of the hands are associated with HPV 4
(Jablonska et al., 1985). Histologically, common warts show promi-
nent papillomatosis, acanthosis, hypergranulosis and hyperkeratosis
of the horny layer. There is a marked clearing of the cytoplasm in
granular cells (‘koilocytosis’) and numerous keratohyalin granules
are present. HPV 4 lesions have more pronounced crescentic nuclei.
HPV 2 warts are notoriously persistent, especially when present as
more superﬁcial ‘mosaic’ warts. Florid and persistent warts, usually
associated with HPV 7, are common in ﬁshmongers and meat
handlers where the skin is chronically macerated due to moisture
and cold (Fig. 3).
Plane warts (HPV 3, 10 or 28) are small and less rough,
presenting as ﬂat-topped papules, ﬂesh coloured or lightly pigmen-
ted, especially on light-exposed areas of the face and back of the
hands, usually in multiple crops (Fig. 4). HPV 3 lesions show little
hyperkeratosis, while HPV 10 and 28 lesions are more hyperker-
atotic and can resemble early commonwarts. Plane warts exhibit an
unusual phenomenon in that they often show spontaneous regres-
sion of all present, observed as superﬁcial swelling and rash. This is
associated histologically with marked by T-cell inﬁltrate and acti-
vated Langerhans cells (Oguchi et al., 1981). In adults plane warts
are more frequent in women but are rarely seen in men excepts back of hand. (b) Periungual warts. (c) Florid hand warts in patient with some
Fig. 3. Florid persistent hand warts associated with occupation. (a) From a ﬁsh
handler (HPV7 detected). (b) From a chicken factory worker.
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Calonje, 2011).
For most children, cutaneous HPV infections are simply an
inconvenience with spontaneous resolution occurring in almost 80%
within 2 years (Sterling et al., 2001). Topical salicylic acid solutions
used at home are effective for most cutaneous warts and should
generally be the ﬁrst line therapy, reserving the application of
cryotherapy with dry ice or liquid nitrogen for recalcitrant warts.
Plantar warts
Plantar warts (often called verruca from the Latin meaning
‘little hill’) rarely occur before the age of 5 years and have a peak
distribution at 10–14 years (Fig. 5). They arise most frequently
through barefoot activities and more often in girls exposed to
barefoot dancing and gymnastics. Activities which cause macera-
tion of the skin such as swimming provide an additional risk of
transmission. Infected keratinocytes are shed on to abrasive
surfaces such as diving boards or swimming pool surrounds, thus
spreading virus to the feet of other swimmers.
Deep plantar warts (myrmecia; caused by HPV 1 (Fig. 5a, b);
also by HPV 63) occur most frequently on weight-bearing areas or
pressure points of the feet. Clinical observation shows a rim of
keratin surrounding a softer keratotic plug, with scattered capil-
lary points which bleed on paring down. Histologically, thegranular layer is disorganised due to the endophytic growth, with
prominent koilocytic cells and parakeratotic cells with nuclear
inclusions in the upper layers. Deep plantar warts are painful,
often tender when lateral pressure is applied, but their response to
treatment is generally good. However, pain together with local
haemorrhage and thrombosis causing myrmecia to turn black
(Fig. 5d) is often associated with regression. In contrast, warts
due to HPV 2 and HPV 4, which have a superﬁcial mosaic pattern
and lack prominent keratohyalin granules, tend to be less painful,
but are more persistent and respond poorly to treatment (Fig. 5c).
Rarer types associated with plantar lesions such as epidermoid
cysts include HPV 57 and 60, the latter sometimes pigmented due
to melanin granules in the keratinocytes (Cardoso and Calonje,
2011). HPV 57 is phylogenetically closely related to HPV 2.
Epidermodysplasia verruciformis
Epidermodysplasia verruciformis (EV) was ﬁrst described
almost a century ago by Lewandowsky and Lutz (Orth, 1987;
Leiding and Holland, 2012). EV is a rare autosomal recessive
condition linked to mutation in one of two genes (EVER1 and
EVER2) on the long arm of chromosome 17 (Ramoz et al., 2002), in
which selective depletion of speciﬁc T cell clones is associated with
extensive infection restricted to a sub-set of about 20 β-HPV types.
The EVER genes encode transmembrane proteins which are
important regulators of zinc homoeostasis, loss of which enhances
expression of viral E6 and E7 genes (Lazarczyk et al., 2009).
There are two presenting conditions in EV:i. Disseminated benign plane warts, associated with HPV 3 and
10 which develop in early childhood and persist throughout life
(Fig. 6). These occur mainly on the trunk, neck and extremities
as ﬂat, hypo- or hyperpigmented papules which can coalesce
into scaly patches resembling those of pityriasis versicolor in
which a high level of viral replication occurs in differentiating
keratinocytes. Histologically, EV lesions show hyperkeratosis,
acanthosis and hypergranulosis. Enlarged keratinocytes with
granular and often vacuolated cytoplasm are characteristic
(Fig. 6d).ii. Verrucous lesions which occur on light-exposed areas and have
greater malignant potential. These lesions are associated with
HPV 5 and 8, often with more than one HPV type being
detected, and they contain high copy numbers of HPV genomes
and abundant E6 and E7 transcripts.
The β-HPV genus now comprises more than 40 types (Pﬁster,
2011). They are ubiquitous in the general population (Astori et al.,
1998) and acquired in early infancy (Antonsson et al., 2003), with
hair follicles regarded as the natural reservoir (Boxman et al.,
1997). Their detection in normal skin in healthy adults with no
immune defects suggests that visible lesions are prevented by
immune control. EV-like conditions develop in HIV infected
individuals including children born with HIV in Africa (Cardoso
and Calonje, 2011) and those with other immunodeﬁciencies.
EV-HPV types have also been found in a high proportion of lesions
associated with epithelial hyperproliferation such as psoriasis
(Favre et al., 1998). Current thinking is that EV represents a
primary deﬁciency of innate immunity, or speciﬁcally restricted
to deﬁciency against B-HPVs or both (Orth, 2008).
Persistence and malignant conversion of cutaneous warts
HPV infections are normally controlled by intact cell-mediated
and humoral immune systems. Regression was shown to be largely
driven by cytotoxic T cells and NK cells many years ago, while
protection from subsequent infection with the same HPV type
Fig. 4. Warts on the face. (a) Plane warts on face and in linear arrangement below lip arising from a scratch (Koebner phenomenon). (b) Filiform common beard warts.
(c) Common wart arising at site of nose piercing.
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of antibodies. However, sequestration of HPV in epithelial cells
provides protection for the virus, resulting in inefﬁcient activation
of innate immunity, poor priming of the adaptive response and
persistence of infection (Stanley, 2010).
Patients with cell-mediated immunodeﬁciencies, whether
primary (as in or familial CD4 lymphopaenia), secondary (as in
haematological malignancies HIV positivity) or iatrogenic (as a
result of immunosuppressive therapy) are all therefore at increased
risk of developing extensive, persistent and recurrent warts. Exam-
ples are shown in Fig. 7. Persistence of HPV lesions is a major issue
for effective clinical management of immunosuppressed patients
and can affect their quality of life signiﬁcantly. Up to 40% of renal
allograft recipients in Edinburgh when treatment was more immu-
nosuppressive than current regimes, were shown to develop
cutaneous warts within a year of receiving the graft, rising to more
than 90% in those with graft survival for longer than 15 years
(Benton and Arends, 1996).
While β-HPV are ubiquitous and most cause in-apparent
infections in the general population, a few types are associated
with squamous cell carcinomas (SCC) in EV patients. HPV 5 and
8 account for 90% of the tumours with HPV 14, 17, 20 and 47
accounting for the remainder (Sterling, 2005). Most EV patients
will develop SCC before the age of 40 on sun-exposed sites and the
tumours are locally destructive. Usually they are low grade
carcinomas in situ with some features in common with Bowen's
disease, but others are aggressive and likely to metastasize.
Bowen's disease is an early in situ SCC with 3–5% risk of invasion,which appears as a red scaly patch often on sun-exposed sites in
the elderly, particularly women with fair skin.
Cutaneous EV-associated HPV DNA is also frequently found in
SCC in transplant patients, other immunosuppressed people and
sometimes in non-melanoma skin cancers in immunocompetent
individuals. However, cutaneous HPV types are only weakly trans-
forming in vitro and evidence to link HPVs causally to skin
carcinogenesis is limited by the frequency of infection with β-HPV
types in the general population and by common risk factors for
activation (UV exposure, immunosuppression and hyperprolifera-
tion) (Pﬁster, 2003). Fig. 8 shows an in situ squamous cell carcinoma,
progressing to invasive disease.
On rare occasions, persistent plantar lesions are associated with
the development of verrucous carcinoma (McKee et al., 1981).HPV in mucosal and anogenital skin
Mucosal infections associated with α-HPV types are more
common than cutaneous HPV (Winer et al., 2005) and the majority
are asymptomatic. Around 10% of young women in Scandinavia
developed external genital warts (EGW) before the age of 45 (Kjær
et al., 2007) and while the prevalence of HPV in women with
normal cytology is also estimated at 10% (De Sanjosé et al., 2007),
the incidence of infection may be many times that which is
reported. HPV DNA testing suggests a presence of HPV in 50–
80% of sexually active young men and women (Stanley, 2006).
EGW are the most common sexually transmitted infection with a
Fig. 5. Plantar warts on feet. (a) Deep plantar warts caused by HPV1. (b) Deep plantar wart caused by HPV1. (c) Mosaic plantar wart caused by HPV2. (d) Thrombosed
capillaries in plantar wart due to spontaneous resolution. (Image (d) previously published in Bunney, M.H., Benton, C., Cubie, H.A. (Eds.). 1992. ‘Viral warts’ – Biology and
Treatment, 2nd edition. Oxford University Press. ISBN0-19-262062-2. With permission from surviving authors (Drs. Benton and Cubie).)
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estimated transmission rate between partners of 60% (Woodhall
et al., 2008). Incidence and prevalence peaks in late teens/early
20s as a result of both behavioural and biological factors. Pre-
valence declines until around age 50–55, when there is a second-
ary peak in many countries, associated either with reactivation of
latent virus or incident new infection due to new sexual partners.
EGW (also known as condylomata acuminata) are found pre-
dominantly at sites traumatised during sexual intercourse. This
includes the glans penis, coronal sulcus and inner aspect of the
foreskin in uncircumscribed men, while infection in circumcised
men is less common and generally restricted to the penile shaft
(Cook et al.,1993). In women, the labia, clitoris, vulva, vagina and
ectocervix can all be infected, with vulvar and vaginal warts
usually plainly visible. In both sexes, HPV can be detected in the
pubis, perineum, urethra and peri-anal area. Intra-anal warts are
most commonly, but not always, a consequence of receptive anal
intercourse.
EGWmay occur as discrete, small, papular or large cauliﬂower-like
lesions on moist surfaces, or as keratotic lesions resembling skin
warts on dry surfaces such as the labia (Fig. 9). They vary in colour
from white, through pink and red to brown and pigmented. Many
EGW are so small that they need a magnifying glass to be seen.
Subclinical lesions may increase in size and number in pregnancy,resulting in increased shedding of HPV from the genital tract,
followed by spontaneous regression after delivery. Vaginal warts
may occasionally grow so large that the birth canal is obstructed.
Symptoms of EGW include itching, bleeding, ﬁssuring and
painful intercourse. Histologically, condylomata show epithelial
thickening due to severe acanthosis and papillomatosis, but with-
out the hyperkeratosis of external cutaneous warts. A chronic
inﬂammatory inﬁltrate is usually observed. The majority of EGW
are associated with HPV 6 and 11, although other LR-HPV types
such as HPV 42 and 81 are common (Clifford et al., 2005; Petry
et al., 2012). HR-HPV may also be detected and about 10–15% may
contain multiple HPV types. Productive virus replication is less
efﬁcient than in cutaneous warts and fewer virus particles are
produced. EGW cause signiﬁcant psychosocial stress and impact
on quality of life, whether by the creation of feelings of guilt and
anxiety, loss of self-esteem or the embarrassment of, and delays in,
seeking treatment (Woodhall et al., 2008). Topical treatment at
home and/or removal by ablation in the clinic setting are often
effective, but only surgical interventions have clearance rates
approaching 100% (Lacey et al., 2011).
Transmission requires close contact, but not necessarily pene-
trative sex (Moscicki et al., 2006). Indeed indirect transmission can
also occur by innocent contact such as sharing baths or towels.
HPV DNA has been isolated from underwear and towels of infected
Fig. 6. Epidermodysplasia verruciformis. (a) Extensive atypical plane warts. (b) EV-like plaque in renal allograft recipient (associated with HPV 5/8). (c) EV-like plaque in
renal allograft recipient (associated with HPV 5/8). (d) Histology of an EV-like lesion showing characteristic large clear cells in spinous and granular layers.
Fig. 7. Recalcitrant warts in immunosuppressed patients. (a) Mosaic plantar wart in liver transplant recipient. (b) Renal allograft recipient 1960s treated with high dose
steroids+azathioprine. (c) Extensive persistent warts from childhood with severe familial CD4 lymphopaenia. (d) Recalcitrant mosaic warts on thumb of young woman after
chemotherapy for Hodgkin's disease. (e) Extensive ﬂat warts on shoulder of HIV infected patient.
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the use of inadequately sterilised instruments and from laser
plumes when inadequate extraction facilities exist (Lacey et al.,
2011). Condoms can protect against acquisition of EGW (Manhart
and Koutsky, 2002).
Vertical transmission of HPV from mother to infant, either in
utero or during delivery, is an important mode of spread of the
virus and is associated with a 1:400 risk of development of
laryngeal papillomatosis or anogenital warts (Lacey et al., 2011),
which may only become clinically apparent months or years later.
Children who present with warts at birth or in the ﬁrst two years
are most likely to have acquired infection through vertical trans-
mission, However, perinatal acquisition of HPV can also occur and
the Finnish family studies show this is often a different HPV type
from that found in either parent (Rintala et al., 2005). While
children over the age of 3 years with ano-genital warts may needpaediatric assessment if sexual abuse is suspected, HPV typing
rarely adds information of value for management and is not
recommended (Lacey et al., 2011). Acquisition of HPV in genital
lesions in children can come from many sources, including direct
inoculation of HPV 2, 27 or 57 from hand warts and transmission
from oral mucosa to genital area by ﬁngers (Jayasinghe and
Garland, 2006).
Additional lesions associated with anogenital HPV infection
include Urethral warts which are rare; complications include reduced
urinary ﬂow and infertility due to obstruction of urethral and
ejaculatory ducts. Bowenoid papulosis, which was originally described in 1977
by Kopf and Bart as reddish-brown verrucous papules on
the penis. Bowenoid papulosis is now known to occur in
Fig. 8. In situ squamous cell carcinoma, progressing to invasive disease – such
lesions can be associated with HPV16.
Fig. 9. Anogenital warts. (a) Anogenital warts in adult. (b) Anogenital warts on labia of child. (c)
recipient. (e) Condylomata acuminate on gland penis a d foreskin (courtesy of Dr. A. McMillan). (
‘Viral warts’ – Biology and Treatment, 2nd edition. Oxford University Press. ISBN0-19-262062-2
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to as a low grade carcinoma in situ and can be treated by
locally destructive methods. While usually benign, they are
associated with HR-HPV types, dysplasia is full thickness,
recurrences are a potential problem and transformation to
malignancy occurs in 2–3%. Bleeding, unusual pigmenta-
tion, ulceration and palpable dermal inﬁltration should be
treated with suspicion and appropriate specialist referral
(Lacey et al., 2011). Giant condyloma acuminatum (Bushcke-Löwenstein tumours),
which is a large exophytic lesions with a verrucous, fungating
surface, frequently found on the penis or in the perianal area
and usually associated with HPV 6 and11. It too is characterised
by local invasion and its distinctive histological appearance, in
which koilocytes and cellular atypia are largely absent, suggest
it is a well-differentiated variant of verrucous carcinoma. Che-
moradiotherapy treatment is associated with good outcomes
(Armstrong et al., 2009).Single genital wart on buttock of child. (d) Extensive perianal warts in renal allograft
Image (e) previously published in Bunney, M.H., Benton, C., Cubie, H.A. (Eds.). 1992.
. With permission from surviving authors (Drs. Benton and Cubie).)
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HPV associated pre-cancers present as intraepithelial neoplasia
and are named after the site: cervical intraepithelial neoplasia (CIN)
for the most commonly recognised and extensively studied conse-
quence of persistent HPV infection, together with VIN and VAIN
(vulval and vaginal intraepithelial neoplasia respectively), PIN (penile
intraepithelial neoplasia) and AIN (anal intraepithelial neoplasia).
Appropriate intervention can usually prevent progression to invasive
cancer, but there is considerable morbidity associated with treatment
of the precancerous stages. In the case of CIN, this can include
pre-term births, increased requirement for caesarian section, low
birth weight and increased deaths (Arbyn et al., 2008).
Cervical intraepithelial neoplasia and cancer
Clinically, precancerous cervical lesions can usually only be
seen with the aid of a colposcope to magnify the epithelium and
application of 5% acetic acid to reveal subclinical lesions which
contain a high level of nuclear material, observed as areas of
densely white whorls known as ﬂat warts (Fig. 10). Microscopic
examination of exfoliated cells scraped with a wooden spatula
from the cervix, ﬁxed, and stained appropriately to revealFig. 10. Anogenital pre-cancers. (a) Colposcopic appearance of ﬂat warts on cervix (CI
in CIN3.dysplastic changes in cells of mucocutaneous epithelium was
developed in the 1940s by Papanicolau (Papanicolaou, 1942). The
technique was introduced for cervical screening in the 1950s/
1960s and into population-based organised screening programmes
in a number of developed countries from the 1990s. Peto et al.
(2004) estimated that 1:80 UK women had been prevented from
developing cervical cancer by accessing the national screening
programme while in the US, it has been estimated that 4 out of
5 women who developed cervical cancer had not had a Pap test in
the previous 5 years (Jemal et al., 2013).
The presence of vacuolated cells with enlarged, hyperchromatic
nuclei described as koilocytes is pathognomonic of productive HPV
infection, while the consequences of persistent infection are reﬂected
in increasingly severe nuclear changes, mitotic ﬁgures and clumps of
pyknotic cells. Observations are classiﬁed in different ways (Table 2)
although the Bethesda classiﬁcation is the most widely accepted,
with low grade squamous intraepithelial neoplasia (LSIL) used for
samples containing cells with larger, irregular and more detailed
nuclei and high grade SIL (HSIL) for samples containing immature
cells, small cells in sheets and syncytial groupings and with distinct
cytoplasmic borders (Fig. 11). Liquid based cytology (LBC), which
allows the creation of a uniform and consistent cell monolayer in theN 3). (b) AIN in long-term renal allograft recipient. (c) Early invasion into stroma
Table 2
Classiﬁcation of cytological and histological abnormalities (adapted from Solomon et al. (2002) and Schiffman et al. (2011)).
Papanicolau
classiﬁcation
Dysplasia classiﬁcation Bethesda classiﬁcation Histology classiﬁcation
I Negative NILM (Negative for intraepithelial lesion or malignancy) Negative
II Squamous atypia ASCUS (Atypical squamous cells of unknown signiﬁcance) Squamous atypia
ASC-H (Atypical squamous cells – cannot exclude HSIL)
Mild LSIL (Low-grade squamous intra-epithelial lesions
encompassing HPV, mild dysplasia and CIN1)
CIN1 (Abnormal cells in 1:3 of layers; very
unlikely to progress)
III
Moderate HSIL (High-grade squamous intra-epithelial lesions,
encompassing; encompassing moderate and severe dysplasia, carcinoma
in situ, CIN2 and CIN3)
CIN2 (Abnormal cells including mitotic ﬁgures in
2:3 of layers
of epithelium with loss of stratiﬁcation and
differentiation)
IV Severe CIS (Carcinoma
in situ)
CIN3 (Abnormal cells across all layers of
epithelium; can
progress to invasive cancer if untreated)
V Carcinoma Carcinoma Carcinoma
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and reduce the number of inadequate samples. LBC has the added
advantage of providing suitable material for HPV testing, while
histological examination of a lesion biopsy will show more speciﬁc
features of HPV infection, such as hypertrophy of the basal layers,
excess keratinisation in the surface layer and overall disorganisation
of the epidermal structure (Fig. 11). CIN lesions are graded according
to the proportion of epithelium affected by abnormalities (Table 2). In
CIN3 there is minimal maturation, nuclear abnormalities throughout
the full thickness and numerous mitotic ﬁgures. The correlation
between cytology and histology is not good, particularly in the
borderline/ASCUS category where 20% will harbour CIN2+ disease
(Solomon et al., 2002).
Most cervical cancers develop in the transformation zone,
which is the junction between squamous cells of the ectocervix
and columnar, glandular cells of the endocervical canal. Early
acquisition of HR-HPV infections can disturb the metaplastic
changes occurring at this time in the transformation zone and
increase the risk of cervical cancer in the future. About 80–90% of
cervical cancers are squamous cell carcinomas (SCC) and 10–20%
are adenocarcinomas, with the percentage of the latter increasing
in recent years. Occasionally cervical cancers have features of both
types and are called adenosquamous or mixed carcinomas. Early
stage SCC may be asymptomatic, but later stages can present with
abnormal vaginal bleeding and discharge, pelvic pain, or pain
during intercourse.
More than 99% of cervical cancers contain HPV DNA, although
the proportion associated with speciﬁc high-risk HPV types (HR-
HPV) is different in different countries and shows demographic,
ethnic and socio-economic variation. The IARC study of over
30,000 cervical cancers showed HPV 16, 18, 58, 33, 45, 31, 52, 35,
59, 39, 51, 56, to be the most common types associated with
invasive cervical cancer with HPV 16 accounting for over 50% and
HPV 16 and 18 for 470% worldwide (Li et al., 2010). Due to the
uneven distribution of HPV DNA in tumour biopsies, the cancers
are thought to be polyclonal in origin. In the US, there are around
10,000 new cases of cervical cancer per year, with higher inci-
dence in black and Hispanic women and also in those with low
educational levels and heightened poverty (Jemal et al., 2013).
Furthermore, cervical cancer is the second most common cancer of
women worldwide with a mean incidence of 35 per 100,000. As
cervical cancer affects women in their child-bearing and econom-
ically active years, the burden of cervical cancer in developing
countries is colossal. Infection with multiple HPV types is common
but is not associated with an increased risk of progression. HPV18
and 45 are more frequently detected in adenocarcinomas which
can be more aggressive lesions.Intraepithelial neoplasia and cancer at other anogenital sites
Recent data shows that asymptomatic anal and perianal carriage
of HPV is common (Nyitray et al., 2008) with a prevalence of 42%
reported in HIV women with high risk behaviours (Palefsky et al.,
2001). A similar squamous columnar junction exists between the
anus and rectum and approximately 10% of AIN will progress to
cancer within 5–10 years, comparable to the progression of CIN3 in
the same time frame. As with CIN, HPV DNA can be demonstrated in
all grades of premalignant anal lesions. In low grade AIN, multiple
types are found in over 50% with roughly one-third containing HPV
16 and one-third containing HPV 6, and HPV 18, 33, 58 and 45
making up the remainder (De Vuyst, 2011). While anal cancer is
numerically relatively uncommon, there are many reports of
signiﬁcant increases in recent years, particularly in men who have
sex with men (MSM) and in HIV positive groups (Palefsky and
Rubin 2009). HIV positive MSM have anal cancer incidences about
three times that of the highest worldwide reported cervical cancer
incidences (Stanley et al., 2012). Nevertheless, despite the higher
risk in MSM and bisexual men, more women develop anal cancer,
particularly those over 50 (Jemal et al., 2013). In Scotland, the
incidence of anal SCC doubled to 0.37 per 100,000 in men and 0.55
in women between 1975 and 2002 (Brewster and Bhatti, 2006).
HPV16 is detectable in an even higher proportion of SCC of the anus
compared with the cervix, with HPV 16 in over 70%, HPV 18 in
around 5%, followed by HPV 33,6 and 31 (de Vuyst, 2011).
The co-factors associated with anogenital malignancies are
similar to those for HPV infection in general, with smoking the
most signiﬁcant. Other risk factors include receptive anal inter-
course, age of ﬁrst exposure to HPV and number of sexual
partners, immune status and genetic background, long-term use
of oral contraceptives and history of EGW. In women, the anatomic
proximity of the vagina to the anus may facilitate non-sexual and
auto-inoculation in women (Moscicki et al., 1999).
Vaginal, vulval and penile cancers are all rare. This is thought to
be because these sites lack a cellular transformation zone in
contrast to both the cervix and anus.
Most penile cancers occur in men over aged 50 and about 50%
are HPV associated. Most are SCC, but a few are verrucous carcino-
mas of the Buschke–Lowenstein type. Symptoms and signs may
include the painless appearance of ﬂat blue-brown growths, red rash
or warty papules under the foreskin, or on the glans or shaft of the
penis; discharge or bleeding may be present. Penile cancer is less
common in males circumcised at birth. While subclinical HPV
infection on the penis can be detected using a colposcope and acetic
acid, it is rarely undertaken and penile cancers present difﬁcult
diagnostic and therapeutic issues. Diagnosis is often delayed because
patients disregard early asymptomatic lesions and there is
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Fig. 11. Cytological and histological images of HPV associated pre-cancers.
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to recent US data (Jemal et al., 2013) the causes, racial and
geographic distribution of penile cancers are similar to those of
cervical cancers.
Vulvar cancer represents only 3% of gynaecological cancers world-
wide (Rumbold et al., 2012). Over the last two decades however, there
has been an increase in vulvar cancer in young women, usually arising
in areas of basaloid or warty VIN. The peak of vulvar cancer incidence
has now shifted from women over 50 to women under 20, with two
different aetiological entities being recognised. Vulvar cancer in young
women is associated with persistent HR-HPV, usually HPV 16 as in
cervical cancer. In post-menopausal women, cancer can arise in vulvar
skin following squamous hyperplasia or lichen sclerosus. Interestingly,
white women in the US are more often affected by vulvar cancer,while blacks and Hispanics present with more vaginal cancers (Jemal
et al., 2013).
Co-infection with HIV and HPV is well known to increase the
risk of cancer at several sites. Recently HPV has also been shown to
be a cofactor in HIV acquisition (Houlihan et al., 2012). In HIV+
women, the higher risk starts with increased cervical HPV detec-
tion and infection, increased persistent infection, and increased
cervical abnormalities/CIN, while in HIV+ men, the increased risk
is for anal HR-HPV infection, persistence and AIN (Hagensee et al.,
2004). In HIV+ women, AIN/anal cancer is found more frequently
in association with CIN/cervical cancer and with the same HPV
types in anus and cervix, compared with HIV women (Hessol
et al., 2013). The greater risk of in situ cancers in HIV+ people is
associated with increasing immunosuppression, but progression to
H.A. Cubie / Virology 445 (2013) 21–3432invasive disease does not appear to be associated with immune
status (Frisch et al., 2000).Head and neck HPV
Oral papillomas
Oral papillomas have been recognised since the 17th century
and are the most common benign tumours of the oral mucosa.
In the Finnish Family HPV study, persistent oral HPV carriage was
detected in 6% of women under 30 years of age and estimates of
adult carriage from other studies range from 5% to 15% (Rintala
et al., 2005). Common warts can spread from the hands to lips by
ﬁnger sucking and nail biting, with cutaneous HPV types identiﬁed
in the lesions. They can become warty on the tongue and hard
palate which has a stratum corneum (Fig. 12a). Other HPV-induced
oral lesions include common warts on the oral mucosa associated
with HPV 2; the multiple soft papules of Heck's disease (focal
epithelial hyperplasia) found most commonly in Eskimos and
North American Indians and associated with HPV 13 or 32; andFig. 12. Oral HPV lesions. (a) Wary lesion resembling condyloma on base of tongue.
(b). Oral lesions in patient with AIDS. (Image (a) previously published in Bunney, M.
H., Benton, C., Cubie, H.A. (Eds.). 1992. ‘Viral warts’ – Biology and Treatment, 2nd
edition. Oxford University Press. ISBN0-19-262062-2. With permission from surviv-
ing authors (Drs. Benton and Cubie).)oral ﬂorid papillomatosis which presents as multiple lesions
on the buccal mucosa. As with EGW, typical virus particles are
found only rarely and in small numbers in oral lesions due to the
lack of keratinisation of the mucosal epithelium. Subclinical
lesions can be detected on the oral mucosa of normal adults after
the application of acetic acid and the associated HPV types are
usually the same as those found in the genital tract. Despite
effective antiretroviral therapy, HIV+ individuals have an increased
risk of acquiring oral warts (Hagensee et al., 2004) (see Fig. 12b).
Laryngeal papillomatosis occurs in both children and adults.
Juvenile onset recurrent respiratory papillomatosis (JORRP) is the
most common benign neoplasm of the larynx in children and
occurs in 4/100,000 live births (Larson and Derkay, 2010). JORRP is
acquired either during birth or in utero from a mother with current
HPV infection in the cervix or with genital warts. It presents with
an abnormal cry and/or hoarseness of voice due to pressure on
vocal cords, has a peak incidence in children under 5 and is
characterised by the presence of HPV 6 or 11 exophytic warty
lesions. These consist of a vascular connective tissue core covered
by hyperplastic stratiﬁed epithelium. JORRP can be life-threaten-
ing, as rapid growth of the lesions can easily block the small
airway, making surgical intervention essential and life-saving.
Some children can require surgery as often as monthly. Recur-
rences are frequent, morbidity is high, treatment is challenging,
management is difﬁcult for both patients and their families and
the costs to healthcare are high.
The incidence of RRP in adults is lower (2/100,000) with a peak
incidence around aged 20 and acquisition is thought to occur through
orogenital contact with an infected partner. While the most common
site of infection is the larynx, the oral cavity, trachea, bronchi, lung
parenchyma and oesophagus can also be infected (Kashima et al.,
1993). Recurrence of tumours of the upper respiratory tract, exten-
sion into the lower airway in approximately 17% of patients and
malignant conversion in 3–4% make clinical management difﬁcult
(Steinberg et al., 1988). HPV 11 infections are more aggressive than
those caused by HPV 6, are more likely to migrate further down the
airway and show a higher malignant conversion rate (Katsenos and
Becker, 2011). The rare pulmonary and oesophageal lesions asso-
ciated with HPV are almost invariably fatal.HPV associated oral cancers
There are about 650,000 new cases of head and neck cancer
annually worldwide, the majority of which (75–80%) occur in men
and are associated with alcohol and smoking in the West and
chewing of tobacco and betel nuts in South East Asia. While the
overall incidence is declining, the proportion of oropharyngeal
cancers has increased rapidly in recent years in several countries.
For example, incidence in the UK increased by 51% between 1989
and 2006 and in the USA by 22% between 1999 and 2006
(Mehanna et al., 2010). This increase has been greatest in indivi-
duals under 50 years old, is linked to the proportion of tumours
which harbour HPV, without the traditional risk factors of smoking
and alcohol consumption and is limited to cancers of lingual and
palatine tonsils, base of tongue and back of the throat (Jemal et al.,
2013). HPV 16 is even more dominant than in cervical cancers and
the increase in HPV positive oral cancers is presumed to be
associated with changes in sexual behaviours, including oral sex.
Further details of the changing pattern of HPV-positive head and
neck cancers can be found in the recent systematic review by
Syrjanen et al. (2011).
Five year survival from oropharyngeal cancer is o50%, largely
due to lack of visible lesions and therefore often late presentation,
but the prognosis for HPV positive cases is better (Goon et al.,
2009), prompting a new area of clinical research concentrating on
H.A. Cubie / Virology 445 (2013) 21–34 33de-escalation of treatment in this subgroup and in new diagnostics
to aid patient management.Concluding remarks
The range of infections, precancers and malignancies associated
with HPV continues to grow. While much effort worldwide
focusses on the potential to eradicate cervical cancer by HPV
vaccination programmes targeting pre-sexually active girls, the
burden of disease is increasing in other areas, particularly with the
high prevalence of genital warts and of anal and oropharyngeal
cancers, in both men and women. It is important also to recognise
the morbidity of cutaneous HPV lesions, particularly in the
immunosuppressed population. HPVs remain both highly effective
pathogens and carcinogens, well adapted to their ecological
niches, capable of avoiding immune responses and therefore
challenging to eliminate.Acknowledgments
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